- Home
- Publications
- Publication Search
- Publication Details
Title
VHH-Based Bispecific Antibodies Targeting Cytokine Production
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-09-01
DOI
10.3389/fimmu.2017.01073
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Can we design a better anti-cytokine therapy?
- (2017) Marina S. Drutskaya et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies
- (2017) Elie Dheilly et al. MOLECULAR THERAPY
- Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
- (2017) Christiane R Stadler et al. NATURE MEDICINE
- Constitutive smooth muscle tumour necrosis factor regulates microvascular myogenic responsiveness and systemic blood pressure
- (2017) Jeffrey T. Kroetsch et al. Nature Communications
- Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions
- (2017) Els Beirnaert et al. Frontiers in Immunology
- Single domain antibody-based bispecific antibody induces potent specific anti-tumor activity
- (2016) Jing Li et al. CANCER BIOLOGY & THERAPY
- A revolutionary therapeutic approach for psoriasis: bispecific biological agents
- (2016) T. Torres et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- IL-6 promotes the differentiation of a subset of naive CD8 + T cells into IL-21–producing B helper CD8 + T cells
- (2016) Rui Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cell-type–restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
- (2016) Grigory A. Efimov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bispecific antibodies in cancer immunotherapy
- (2016) Siqi Chen et al. Human Vaccines & Immunotherapeutics
- Overcoming the Constraints of Anti-HIV/CD89 Bispecific Antibodies That Limit Viral Inhibition
- (2016) Xiaocong Yu et al. Journal of Immunology Research
- TNF Neutralization Results in the Delay of Transplantable Tumor Growth and Reduced MDSC Accumulation
- (2016) Kamar-Sulu N. Atretkhany et al. Frontiers in Immunology
- A Dual Target-directed Agent against Interleukin-6 Receptor and Tumor Necrosis Factor α ameliorates experimental arthritis
- (2016) Youngkyun Kim et al. Scientific Reports
- Blinatumomab for the Treatment of Philadelphia Chromosome-Negative, Precursor B-cell Acute Lymphoblastic Leukemia
- (2015) O. Wolach et al. CLINICAL CANCER RESEARCH
- Bispecific antibodies
- (2015) Roland E. Kontermann et al. DRUG DISCOVERY TODAY
- Control of Mycobacterial Infections in Mice Expressing Human Tumor Necrosis Factor (TNF) but Not Mouse TNF
- (2015) Maria L. Olleros et al. INFECTION AND IMMUNITY
- Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury
- (2015) Alaa S. Awad et al. KIDNEY INTERNATIONAL
- Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases
- (2015) Michela Silacci et al. mAbs
- Noninvasive imaging of immune responses
- (2015) Mohammad Rashidian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Mass Spectrometric-Derived Cell Surface Protein Atlas
- (2015) Damaris Bausch-Fluck et al. PLoS One
- Generation and Characterization of Small Single Domain Antibodies Inhibiting Human Tumor Necrosis Factor Receptor 1
- (2014) Sophie Steeland et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
- (2014) Y. J. Yu et al. Science Translational Medicine
- Selective Tumor Necrosis Factor Receptor I Blockade Is Antiinflammatory and Reveals Immunoregulatory Role of Tumor Necrosis Factor Receptor II in Collagen-Induced Arthritis
- (2014) Fiona E. McCann et al. Arthritis & Rheumatology
- Combined Inhibition of Tumor Necrosis Factor α and Interleukin-17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody
- (2014) Jens A. A. Fischer et al. Arthritis & Rheumatology
- Selective Blockade of Tumor Necrosis Factor Receptor I Inhibits Proinflammatory Cytokine and Chemokine Production in Human Rheumatoid Arthritis Synovial Membrane Cell Cultures
- (2013) Emily M. Schmidt et al. ARTHRITIS AND RHEUMATISM
- Prominent role for T cell-derived Tumour Necrosis Factor for sustained control of Mycobacterium tuberculosis infection
- (2013) Nasiema Allie et al. Scientific Reports
- A bispecific antibody against IL-1β and IL-17A is beneficial for experimental rheumatoid arthritis
- (2012) Jianying Qi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dual targeting strategies with bispecific antibodies
- (2012) Roland Kontermann mAbs
- A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
- (2012) Takehisa Kitazawa et al. NATURE MEDICINE
- Pathogenic and Protective Functions of TNF in Neuroinflammation Are Defined by Its Expression in T Lymphocytes and Myeloid Cells
- (2011) A. A. Kruglov et al. JOURNAL OF IMMUNOLOGY
- Human single-chain variable fragment that specifically targets arthritic cartilage
- (2010) Chris Hughes et al. ARTHRITIS AND RHEUMATISM
- Cellular source and molecular form of TNF specify its distinct functions in organization of secondary lymphoid organs
- (2010) A. V. Tumanov et al. BLOOD
- ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock
- (2010) Udo Conrad et al. PLANT BIOTECHNOLOGY JOURNAL
- Transglutaminase-catalyzed covalent multimerization of camelidae anti-human TNF single domain antibodies improves neutralizing activity
- (2009) Ingo Plagmann et al. JOURNAL OF BIOTECHNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now